Motor neuron disease: Benefits of nusinersen extend to later-onset SMA
- PMID: 29497154
- DOI: 10.1038/nrneurol.2018.24
Motor neuron disease: Benefits of nusinersen extend to later-onset SMA
Comment on
-
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.N Engl J Med. 2018 Feb 15;378(7):625-635. doi: 10.1056/NEJMoa1710504. N Engl J Med. 2018. PMID: 29443664 Clinical Trial.
References
-
- N Engl J Med. 2018 Feb 15;378(7):625-635 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical